Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources

Publication date

2020-05-31T17:31:54Z

2020-05-31T17:31:54Z

2019-12

2020-05-31T17:31:54Z

Abstract

Neuroendocrine tumours (NETs) are rare malignancies characterised by its capacity to synthesise and secrete monoamines, due to its neuroendocrine origin. Its varied locations and symptoms have traditionally been responsible for extended delays in their diagnosis. The interest of this study was to characterise the patient population diagnosed with NETs in Spain and to revise how the disease is managed, together with the hospitalisation costs of these patients. (...)

Document Type

Article


Published version

Language

English

Publisher

BioMed Central

Related items

Reproducció del document publicat a: https://doi.org/10.1186/s12885-019-6412-8

BMC Cancer, 2019, vol. 19, num. 1226, p. 01-07

https://doi.org/10.1186/s12885-019-6412-8

Recommended citation

This citation was generated automatically.

Rights

cc-by (c) Darbà, Josep et al., 2019

http://creativecommons.org/licenses/by/3.0/es

This item appears in the following Collection(s)